{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:11Z","timestamp":1786982771603,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40268-025-00512-x","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:36:00Z","timestamp":1748428560000},"page":"99-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Opinion of the Italian Association of Myology on Ataluren for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-6525","authenticated-orcid":false,"given":"Luca","family":"Bello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Riguzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Albamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guja","family":"Astrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Battini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Barp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Berardinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico S.","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Brolatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Dallavalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Minetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Mongini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olimpia","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Panicucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pedemonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Politano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Previtali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Trabacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Trucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Velardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo P.","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"6","key":"512_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51(6):919\u201328.","journal-title":"Cell"},{"key":"512_CR2","unstructured":"Bello L, Hoffman EP, Pegoraro E. Dystrophinopathies. In: Muscular dystrophy: causes and management. 2013. Editor: Angelini C. Nova Science Publishers, Inc. (New York City, NY, USA). p. 67\u201396."},{"issue":"10119","key":"512_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","volume":"391","author":"CM McDonald","year":"2018","unstructured":"McDonald CM, Henricson EK, Abresch RT, et al. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet. 2018;391(10119):451\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(17)32160-8.","journal-title":"Lancet"},{"issue":"5","key":"512_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/acn3.51046","volume":"7","author":"L Bello","year":"2020","unstructured":"Bello L, D\u2019Angelo G, Villa M, et al. Genetic modifiers of respiratory function in Duchenne muscular dystrophy. Ann Clin Transl Neurol. 2020;7(5):786\u201398. https:\/\/doi.org\/10.1002\/acn3.51046.","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"512_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S2213-2600(21)00581-6","volume":"10","author":"DJ Birnkrant","year":"2022","unstructured":"Birnkrant DJ, Bello L, Butterfield RJ, et al. Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges. Lancet Respir Med. 2022;10(4):403\u201320. https:\/\/doi.org\/10.1016\/S2213-2600(21)00581-6.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"512_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","volume":"34","author":"A Aartsma-Rus","year":"2006","unstructured":"Aartsma-Rus A, Van Deutekom JCT, Fokkema IF, Van Ommen GJB, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve. 2006;34(2):135\u201344. https:\/\/doi.org\/10.1002\/mus.20586.","journal-title":"Muscle Nerve"},{"issue":"7140","key":"512_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature05756","volume":"447","author":"EM Welch","year":"2007","unstructured":"Welch EM, Barton ER, Zhuo J, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature. 2007;447(7140):87\u201391. https:\/\/doi.org\/10.1038\/nature05756.","journal-title":"Nature"},{"issue":"12","key":"512_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081302","volume":"8","author":"RS Finkel","year":"2013","unstructured":"Finkel RS, Flanigan KM, Wong B, et al. Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy. PLoS ONE. 2013;8(12): e81302. https:\/\/doi.org\/10.1371\/journal.pone.0081302.","journal-title":"PLoS ONE"},{"issue":"4","key":"512_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/mus.24332","volume":"50","author":"K Bushby","year":"2014","unstructured":"Bushby K, Finkel R, Wong B, et al. Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve. 2014;50(4):477\u201387. https:\/\/doi.org\/10.1002\/mus.24332.","journal-title":"Muscle Nerve"},{"issue":"10101","key":"512_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","volume":"390","author":"CM McDonald","year":"2017","unstructured":"McDonald CM, Campbell C, Torricelli RE, et al. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10101):1489\u201398. https:\/\/doi.org\/10.1016\/S0140-6736(17)31611-2.","journal-title":"Lancet"},{"key":"512_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000202505","author":"CM McDonald","year":"2023","unstructured":"McDonald CM, Wu S, Gulati S, et al. Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial (PL5.001). Neurology. 2023. https:\/\/doi.org\/10.1212\/WNL.0000000000202505.","journal-title":"Neurology"},{"key":"512_CR12","unstructured":"MDA Clinical & Scientific Conference. Ataluren slows the decline of muscle function in patients with nmDMD: a meta-analysis of three randomized, double-blind, placebo-controlled trials [poster]. https:\/\/www.mdaconference.org\/abstract-library\/ataluren-slows-the-decline-of-muscle-function-in-patients-with-nmdmd-a-meta-analysis-of-three-randomized-double-blind-placebo-controlled-trials\/. Accessed 13 May 2025."},{"issue":"14","key":"512_CR13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2217\/cer-2020-0095","volume":"9","author":"C Campbell","year":"2020","unstructured":"Campbell C, Barohn RJ, Bertini E, et al. Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy. J Comp Eff Res. 2020;9(14):973\u201384. https:\/\/doi.org\/10.2217\/cer-2020-0095.","journal-title":"J Comp Eff Res."},{"issue":"4","key":"512_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1474-4422(24)00036-X","volume":"23","author":"E Mercuri","year":"2024","unstructured":"Mercuri E, Vilchez JJ, Boespflug-Tanguy O, et al. Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2024;23(4):393\u2013403. https:\/\/doi.org\/10.1016\/S1474-4422(24)00036-X.","journal-title":"Lancet Neurol"},{"issue":"1","key":"512_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41591-024-03304-z","volume":"31","author":"JR Mendell","year":"2025","unstructured":"Mendell JR, Muntoni F, McDonald CM, et al. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial. Nat Med. 2025;31(1):332\u201341. https:\/\/doi.org\/10.1038\/s41591-024-03304-z.","journal-title":"Nat Med"},{"issue":"8","key":"512_CR16","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1007\/s00415-023-11687-1","volume":"270","author":"E Mercuri","year":"2023","unstructured":"Mercuri E, Osorio AN, Muntoni F, et al. Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015\u20132022): 2022 interim analysis. J Neurol. 2023;270(8):3896\u2013913. https:\/\/doi.org\/10.1007\/s00415-023-11687-1.","journal-title":"J Neurol"},{"issue":"1","key":"512_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/mus.23807","volume":"48","author":"CM McDonald","year":"2013","unstructured":"McDonald CM, Henricson EK, Abresch RT, et al. The cooperative international neuromuscular research group Duchenne natural history study: a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used. Muscle Nerve. 2013;48(1):32\u201354. https:\/\/doi.org\/10.1002\/mus.23807.","journal-title":"Muscle Nerve"},{"key":"512_CR18","unstructured":"PTC Therapeutics. Translarna\u2122 Study 045 and clinical update. https:\/\/ir.ptcbio.com\/static-files\/8303ae51-2679-441f-b268-8e7b2bcda9f4. Accessed 13 May 2025."},{"key":"512_CR19","unstructured":"EMA. Translarna. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/translarna. Accessed 13 May 2025."},{"issue":"S1","key":"512_CR20","doi-asserted-by":"publisher","first-page":"104441.123","DOI":"10.1016\/j.nmd.2024.07.132","volume":"43","author":"F Muntoni","year":"2024","unstructured":"Muntoni F, Buccella F, Osorio AN, et al. 395P Age at loss of ambulation in patients with nmDMD from the STRIDE Registry: sensitivity analyses. Neuromuscul Disord. 2024;43(S1):104441.123. https:\/\/doi.org\/10.1016\/j.nmd.2024.07.132.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"512_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1212\/WNL.0000000000002337","volume":"86","author":"D Gloss","year":"2016","unstructured":"Gloss D, Moxley RT, Ashwal S, Oskoui M. Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016;86(5):465\u201372. https:\/\/doi.org\/10.1212\/WNL.0000000000002337.","journal-title":"Neurology"},{"issue":"4","key":"512_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17(4):347\u201361. https:\/\/doi.org\/10.1016\/S1474-4422(18)30025-5.","journal-title":"Lancet Neurol"},{"issue":"15","key":"512_CR23","doi-asserted-by":"publisher","first-page":"e1540","DOI":"10.1212\/WNL.0000000000201626","volume":"100","author":"F Muntoni","year":"2023","unstructured":"Muntoni F, Signorovitch J, Sajeev G, et al. DMD genotypes and motor function in Duchenne muscular dystrophy: a multi-institution meta-analysis with implications for clinical trials. Neurology. 2023;100(15):e1540\u201354. https:\/\/doi.org\/10.1212\/WNL.0000000000201626.","journal-title":"Neurology"},{"issue":"4","key":"512_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1212\/WNL.0000000000002891","volume":"87","author":"L Bello","year":"2016","unstructured":"Bello L, Morgenroth LP, Gordish-Dressman H, Hoffman EP, McDonald CM, Cirak S. DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study. Neurology. 2016;87(4):401\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000002891.","journal-title":"Neurology"},{"issue":"8","key":"512_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237803","volume":"15","author":"A Torella","year":"2020","unstructured":"Torella A, Zanobio M, Zeuli R, et al. The position of nonsense mutations can predict the phenotype severity: a survey on the DMD gene. PLoS ONE. 2020;15(8): e0237803. https:\/\/doi.org\/10.1371\/journal.pone.0237803.","journal-title":"PLoS ONE"},{"issue":"12","key":"512_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.nmd.2015.10.007","volume":"25","author":"V Ricotti","year":"2015","unstructured":"Ricotti V, Muntoni F, Voit T. Challenges of clinical trial design for DMD. Neuromuscul Disord. 2015;25(12):932\u20135. https:\/\/doi.org\/10.1016\/j.nmd.2015.10.007.","journal-title":"Neuromuscul Disord"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-025-00512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40268-025-00512-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-025-00512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T11:55:29Z","timestamp":1750679729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40268-025-00512-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1007\/s40268-025-00512-x","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"4 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"LB, EA, ESB, CB, GPC, LM, RM, EM, VN, MP, LR, and AT declare personal fees from PTC Therapeutics for participation in advisory boards or as speaker honoraria. LB, ESB, ADA, EM, AP, and LR declare research funding to the respective institutions from PTC Therapeutics. PTC Therapeutics has unconditionally funded the annual conferences and other educational events organized by the Italian Association of Myology. All other authors have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable (no new data were generated).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable (no new data were generated).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable (no code was generated).","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"LB drafted the manuscript. All authors reviewed and edited the manuscript for intellectual content, and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}